Nuveen Large Cap Value Fund
TIAA-CREF Funds · 6 share classes
Fund classification
Classified from what the fund holds · as of 2026 Q2
Nuveen Large Cap Value Fund is an actively managed U.S. equity fund. 5% of TRLIX’s stock holdings are in companies whose revenue grew in the top quartile of U.S. companies over the last five fiscal years (covering 99% of the fund’s equity).
- Asset class
- Equity
- Region
- United States
- Management
- Actively managed
- Fund type
- Open-end fund
Fund profile
As filed in the prospectus · 2026 Q1
The Fund seeks a favorable long-term total return, mainly through capital appreciation, primarily from equity securities of large domestic companies.
The fund invests in large-capitalization U.S. equity securities that its adviser identifies as undervalued based on comparative valuation metrics including price-to-book, price-to-earnings, dividend yield, and free cash flow, with holdings drawn from value-oriented indexes. The fund focuses on companies with normalized earnings and high operating leverage, which may amplify volatility during market downturns. Up to 20% of assets may be invested in foreign securities.
| Share class | Gross | Net |
|---|---|---|
| TRLIX | 0.40% | 0.40% |
| TCLCX | 0.74% | 0.74% |
| TRLCX | 0.65% | 0.65% |
| TRCPX | 0.55% | 0.55% |
| TRLHX | 0.43% | 0.43% |
| TRLWX | 0.40% | 0.00% |
Net is what a holder pays after the adviser's contractual waiver; gross is before it. A waiver can expire.
Portfolio turnover 17.00% · as of 2026 Q1
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 99.78% |
| Cash & short-term | 0.19% |
Sector allocation
The same holdings as Allocation above, grouped by market sector instead of asset type · as of 2026 Q2
| Financials | 22.3% |
| Industrials | 15.8% |
| Information Technology | 13.2% |
| Health Care | 11.0% |
| 8 smaller | 37.6% |
Government, Securitized and Cash are non-corporate buckets; International is foreign holdings we don’t sector-classify, and Other is the residual (held funds, unresolved names).
Portfolio growth profile
How much of the fund’s stock holdings are in fast-growing companies · as of 2026 Q2
Share of the fund’s equity (by value) in companies whose trailing five-year revenue — or net-income — growth ranks in the top 25% of U.S. public companies. Foreign and newly-listed holdings are excluded, so the figure covers only part of the book. From SEC filings — not investment advice. How we measure this.
Latest quarter
What changed since the fund's previous filing
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
| Share class | 1-year | 3-year | 5-year | Vol | Worst fall |
|---|---|---|---|---|---|
| +27.24% | +61.20% | +68.14% | 10.43% | -8.38% | |
| +26.88% | +59.76% | +65.67% | 10.44% | -8.48% | |
| +26.94% | +59.99% | +66.06% | 10.39% | -8.47% | |
| +27.03% | +60.42% | +66.82% | 10.42% | -8.50% | |
| +27.26% | +60.99% | +67.69% | 10.44% | -8.44% | |
| +27.76% | +63.23% | +71.64% | 10.43% | -8.32% |
These classes hold the same portfolio, so the 5.97pp spread over 5 years is the cost difference between them — roughly 1.19pp a year — not a difference in what they own.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| GOOG | Alphabet IncGOOG | 5.23% | $381.94 | $335.40M | 878.2K |
| JPM | JPMorgan Chase & CoJPM | 3.84% | $313.23 | $246.01M | 785.4K |
| JNJ | Johnson & JohnsonJNJ | 2.76% | $229.85 | $177.00M | 770.1K |
| AMZN | Amazon.com IncAMZN | 2.52% | $265.06 | $161.91M | 610.8K |
| XOM | Exxon Mobil CorpXOM | 2.30% | $154.33 | $147.23M | 954.0K |
| BRK/B | Berkshire Hathaway IncBRK/B | 2.24% | $473.60 | $143.86M | 303.8K |
| BAC | Bank of America CorpBAC | 2.18% | $53.46 | $139.75M | 2.6M |
| RTX | RTX CorpRTX | 1.97% | $176.07 | $126.22M | 716.9K |
| WFC | Wells Fargo & CoWFC | 1.92% | $82.23 | $123.37M | 1.5M |
| GS | The Goldman Sachs Group IncGS | 1.89% | $923.77 | $121.21M | 131.2K |
Reported price is the fund's own reported value divided by its own reported shares at 2026-04-30 — not a live quote, and not what the fund paid.
Top 10 positions are 26.86% of net assets, top 25 51.30%, across 77 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free